AUROPHARMA.NS vs. ^NIFTY200

Last updated Jun 5, 2026

AUROPHARMA.NS (Aurobindo Pharma Limited) is a stock, while ^NIFTY200 (NIFTY 200) is an index. Over the past 10 years, AUROPHARMA.NS returned 7.07%/yr vs 12.20%/yr for ^NIFTY200. At a 0.42 correlation, their price movements are largely independent.

Performance

AUROPHARMA.NS vs. ^NIFTY200 - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Aurobindo Pharma Limited (AUROPHARMA.NS) and NIFTY 200 (^NIFTY200). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AUROPHARMA.NS achieves a 23.72% return, which is significantly higher than ^NIFTY200's -6.77% return. Over the past 10 years, AUROPHARMA.NS has underperformed ^NIFTY200 with an annualized return of 7.07%, while ^NIFTY200 has yielded a comparatively higher 12.20% annualized return.

AUROPHARMA.NS

• 1D: 1.61%
• 1M: 2.49%
• YTD: 23.72%
• 6M: 19.66%
• 1Y: 29.05%
• 3Y*: 30.82%
• 5Y*: 9.48%
• 10Y*: 7.07%

^NIFTY200

• 1D: 0.16%
• 1M: -1.59%
• YTD: -6.77%
• 6M: -6.34%
• 1Y: -1.61%
• 3Y*: 11.52%
• 5Y*: 10.29%
• 10Y*: 12.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

AUROPHARMA.NS vs. ^NIFTY200 - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AUROPHARMA.NS Aurobindo Pharma Limited	23.72%	-11.09%	23.22%	150.11%	-39.53%	-19.94%	102.47%	-37.32%	7.05%	3.26%
^NIFTY200 NIFTY 200	-6.77%	8.40%	13.63%	23.49%	3.65%	27.47%	15.62%	8.68%	-1.01%	33.43%

Correlation

The correlation between AUROPHARMA.NS and ^NIFTY200 is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.34
Correlation (3Y) Calculated over the trailing 3-year period	0.36
Correlation (5Y) Calculated over the trailing 5-year period	0.39
Correlation (10Y) Calculated over the trailing 10-year period	0.42
Correlation (All Time) Calculated using the full available price history since Jan 5, 2004	0.42

Return for Risk

AUROPHARMA.NS vs. ^NIFTY200 — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AUROPHARMA.NS

AUROPHARMA.NS Risk / Return Rank: 73
AUROPHARMA.NS Sharpe Ratio Rank: 75
AUROPHARMA.NS Sortino Ratio Rank: 69
AUROPHARMA.NS Omega Ratio Rank: 69
AUROPHARMA.NS Calmar Ratio Rank: 76
AUROPHARMA.NS Martin Ratio Rank: 76

^NIFTY200

^NIFTY200 Risk / Return Rank: 7
^NIFTY200 Sharpe Ratio Rank: 7
^NIFTY200 Sortino Ratio Rank: 6
^NIFTY200 Omega Ratio Rank: 6
^NIFTY200 Calmar Ratio Rank: 9
^NIFTY200 Martin Ratio Rank: 8

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AUROPHARMA.NS vs. ^NIFTY200 - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aurobindo Pharma Limited (AUROPHARMA.NS) and NIFTY 200 (^NIFTY200). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AUROPHARMA.NS	^NIFTY200	Difference
Sharpe ratio: Return per unit of total volatility	1.14	-0.12	+1.26
Sortino ratio: Return per unit of downside risk	1.69	-0.07	+1.77
Omega ratio: Gain probability vs. loss probability	1.22	0.99	+0.23
Calmar ratio: Return relative to maximum drawdown	2.10	-0.11	+2.21
Martin ratio: Return relative to average drawdown	5.03	-0.35	+5.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AUROPHARMA.NS vs. ^NIFTY200 - Sharpe Ratio Comparison

The current AUROPHARMA.NS Sharpe Ratio is 1.14, which is higher than the ^NIFTY200 Sharpe Ratio of -0.12. The chart below compares the historical Sharpe Ratios of AUROPHARMA.NS and ^NIFTY200, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	AUROPHARMA.NS	^NIFTY200	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.14	-0.12	+1.26
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.33	0.73	-0.40
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.20	0.76	-0.56
Sharpe Ratio (All Time) Calculated using the full available price history	0.45	0.59	-0.14

Drawdowns

AUROPHARMA.NS vs. ^NIFTY200 - Drawdown Comparison

The maximum AUROPHARMA.NS drawdown since its inception was -86.50%, which is greater than ^NIFTY200's maximum drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for AUROPHARMA.NS and ^NIFTY200.

Drawdown Indicators

	AUROPHARMA.NS	^NIFTY200	Difference
Max Drawdown Largest peak-to-trough decline	-86.50%	-64.04%	-22.46%
Max Drawdown (1Y) Largest decline over 1 year	-13.85%	-14.89%	+1.04%
Max Drawdown (3Y) Largest decline over 3 years	-34.57%	-18.08%	-16.49%
Max Drawdown (5Y) Largest decline over 5 years	-59.50%	-18.15%	-41.35%
Max Drawdown (10Y) Largest decline over 10 years	-65.37%	-38.22%	-27.15%
Current Drawdown Current decline from peak	-6.31%	-8.38%	+2.07%
Average Drawdown Average peak-to-trough decline	-31.09%	-10.96%	-20.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.78%	4.62%	+1.16%

Volatility

AUROPHARMA.NS vs. ^NIFTY200 - Volatility Comparison

Aurobindo Pharma Limited (AUROPHARMA.NS) has a higher volatility of 6.85% compared to NIFTY 200 (^NIFTY200) at 4.01%. This indicates that AUROPHARMA.NS's price experiences larger fluctuations and is considered to be riskier than ^NIFTY200 based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AUROPHARMA.NS	^NIFTY200	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.85%	4.01%	+2.84%
Volatility (6M) Calculated over the trailing 6-month period	19.35%	12.10%	+7.25%
Volatility (1Y) Calculated over the trailing 1-year period	25.46%	13.72%	+11.74%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	29.34%	14.32%	+15.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.96%	16.28%	+19.68%

Frequently Asked Questions

Can I hold both AUROPHARMA.NS and ^NIFTY200 in my portfolio?

AUROPHARMA.NS and ^NIFTY200 have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.